MedWatch

The Danish Chamber of Commerce: Cuts and lacks in research are poisoning the life science industry

The political ambitions of Danish life science are too low. Denmark’s lead position is at risk if politicians do not improve the conditions for the researchers and companies that are to create the drugs and hospital devices in future, says the Danish Chamber of Commerce's head of health policy.

Foto: Dansk Erhverv

The Danish life science industry is a hard-working(??) growth engine with 48,000 employees, DKK 21 billion (USD 3.19 billion) in tax payments and 16 percent of the total Danish export equal to DKK 108 billion (USD 16.39 billion).

But the industry rests on a slender oundation and if the working conditions do not improve, Denmark risks losing its otherwise well-deserved lead position in life science, says the industry association, Danish Chamber of Commerce.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Headhunter: Afgående Leo-boss var et flop

Det var et fejlskud at ansætte Catherine Mazzacco som adm. direktør for Leo Pharma, vurderer headhunter, der ser afgangen som et naturligt skridt forud for børsnoteringen af Leo Pharma. Til at styre den proces i mål vil bestyrelsen efter alt at dømme skulle til udlandet for at finde den rette profil, lyder det videre.

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier